Sign in

CIK 0001728117

  • Non-accelerated filer
  • Smaller reporting company

Gossamer Bio, Inc.

Sign in to watch
Ticker
GOSS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475461709
Phone
+1 858-684-1300
Business address
3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 6 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-20 Carter Laura Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +157,500 157,500
2023-03-16 Carter Laura Chief Scientific Officer Sale −6,029 $1.10 $7K 76,263
2022-12-07 Carter Laura Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +157,500 157,500
2022-10-24 Carter Laura Chief Scientific Officer Sale −4,876 $12.07 $59K 82,292
2022-10-24 Carter Laura Chief Scientific Officer Sale −4,876 $12.07 $59K 82,292
2022-07-15 Carter Laura Chief Scientific Officer Purchase +6,934 $7.21 $50K 87,168
2022-07-01 Carter Laura Chief Scientific Officer Sale −8,808 $8.25 $73K 80,234
2022-05-04 Carter Laura Chief Scientific Officer Sale −1,262 $7.20 $9K 89,042
2022-03-16 Carter Laura Chief Scientific Officer Sale −5,002 $8.28 $41K 90,304
2022-01-06 Carter Laura Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +190,000 190,000
2021-10-25 Carter Laura Chief Scientific Officer Sale −2,377 $12.25 $29K 95,306
2021-06-30 Carter Laura Chief Scientific Officer Grant or award +25,000 97,683
2021-05-03 Carter Laura Chief Scientific Officer Grant or award +10,820 72,683
2021-05-03 Carter Laura Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +31,750 31,750

Page 1 of 1 · 14 trades